Last reviewed · How we verify

NCT03453554

Evaluating a Digital Memory Notebook App to Improve Functional Independence

Status unknown NA Last updated 9 October 2018
What this trial tests

NA trial testing Digital Notebook app in Mild Cognitive Impairment in 30 participants. Status unknown.

Timeline
1 August 2018
Primary endpoint
30 August 2021
30 August 2021

Quick facts

Lead sponsorWashington State University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment30
Start date1 August 2018
Primary completion30 August 2021
Estimated completion30 August 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Washington State University

Who can join

40 and older, any sex, with Mild Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will investigate the efficacy of a smart home / digital memory notebook (DMN) partnership that will allow for real-time intervention and thereby facilitate acquisition and use of the DMN to support everyday independence. The DMN is an app that is installed on a mobile tablet. The smart home technology discovers and recognizes generalizable activities and provides information about functional status and health-related variables for older adult participants. This study will examine how smart home prompts affect individuals' DMN use, ability to maintain activity routines, and overall wellbeing. Prompts will center on helping users organize and schedule daily activities, record both routine and uncommon events that may need to be remembered, and record activities performed and important associated event information (e.g., when, what, where). Prompting will help to promote everyday functional independence by encouraging frequent and regular notebook use and reducing memory difficulties. The DMN will also help to support functional independence by notifying individuals about appointments or prompting individuals to initiate important activities of daily living (e.g., take medications). This study will also involve a machine learning technique to gain a better understanding of the contexts in which individuals adhere or do not adhere to the prompts. This activity-aware intervention will be deployed in the homes of older adults with memory difficulties, to assess the usability of the technology as well as to evaluate in a naturalistic setting the efficacy of the technology for increasing everyday functional independence and quality of life and decreasing care-partner burden. This contribution is significant because it will demonstrate that intelligent technologies can improve the efficacy of traditional memory rehabilitation techniques, extend functional independence, reduce caregiver burden, and improve quality of life.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Partnering a Compensatory Application with Activity-Aware Prompting to Improve Use in Individuals with Amnestic Mild Cognitive Impairment: A Randomized Controlled Pilot Clinical Trial.
    Schmitter-Edgecombe M, Brown K, Luna C, Chilton R, et al · · 2022 · cited 14× · PMID 34776442 · DOI 10.3233/jad-215022
  2. The development of a manual-based digital memory notebook intervention with case study illustrations.
    Chudoba LA, Church AS, Dahmen JB, Brown KD, et al · · 2020 · cited 14× · PMID 31046586 · DOI 10.1080/09602011.2019.1611606
  3. But will they use it? Predictors of adoption of an electronic memory aid in individuals with amnestic mild cognitive impairment.
    Luna C, Cook DJ, Schmitter-Edgecombe M. · · 2023 · cited 3× · PMID 36939601 · DOI 10.1037/neu0000898

Verify or expand the search:

Other recruiting trials for Mild Cognitive Impairment

Currently open trials in the same condition.

Other Washington State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03453554.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing